Secure payment on i-micronews Contact Yole Développement for I Micronews reports

RSS I-micronewsYole Dévelopement on TwitterYole Développement on Google +LinkedIn Yole pageSlideshare Yole Développement I-Micronews

MedTech

POC Medical Systems said that it raised $21 million in Series A financing to fund clinical testing and commercialization of its portable breast cancer screening test, MammoAlert. The round was led by BioVentures Investors and also included Sirius America Insurance Company, IFG Healthcare and MIA Investment Limited.

Read more ...

Harvard University researchers have developed a multiregional brain-on-a-chip that models the connectivity between three distinct regions of the brain. The in vitro model was used to extensively characterize the differences between neurons from different regions of the brain and to mimic the system’s connectivity. The research was published in the Journal of Neurophysiology.

Read more ...

Pixium Vision, a company developing and commercializing innovative bionic vision systems with the intention to allow patients who have lost their sight to lead more independent lives, announces completion of 10 implants in its IRIS II study. All implanted patients will now follow their re-education program as defined in the ongoing European multi-centric study for IRIS II which was launched in January 2016.

Read more ...

Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that it has entered into a definitive agreement to purchase RainDance Technologies. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during the first quarter of 2017. The company will discuss the acquisition further during Bio-Rad's upcoming fourth-quarter and full-year 2016 financial results conference call.

Read more ...

GenePOC, has received CE marking for its second bacteriological test, GenePOCCDiff, and for its centripetal sample to result instrument, revogene.GenePOC, a member of Debiopharm Group, announced a new phase in its operations after obtaining CE marking for its revogene instrument and its first set of tests for Group B Streptococcus (GBS) and C. difficile.

Read more ...

Illumina and Bio-Rad Laboratories announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference.

Read more ...

Upcoming Events

No events